Antithrombotic therapy in coronary artery disease.
Bertelé
V
V
Salzman
E W
EW
D000925:Anticoagulants / Q000627:therapeutic use*; D003327:Coronary Disease / Q000188:drug therapy*; D004176:Dipyridamole / Q000627:therapeutic use; D005341:Fibrinolysin / Q000096:biosynthesis; D005342:Fibrinolysis; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D009203:Myocardial Infarction / Q000401:mortality / Q000517:prevention & control; D010973:Platelet Adhesiveness; D013300:Streptokinase / Q000378:metabolism; D013442:Sulfinpyrazone / Q000627:therapeutic use; D014859:Warfarin / Q000627:therapeutic use
D000925:Anticoagulants; D014859:Warfarin; D004176:Dipyridamole; D006493:Heparin; D013300:Streptokinase; D005341:Fibrinolysin; D013442:Sulfinpyrazone